These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1080679)

  • 1. The effect of heparin on platelet aggregation by common inductors and by ristocetin in congenital bleeding disorders due to factor VIII or fibrinogen defects.
    Girolami A; De Marco L; Virgolini L; Peruffo R; Fabris F
    Blut; 1975 Oct; 31(4):219-26. PubMed ID: 1080679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ionophore on platelet aggregation in von Willebrand's disease and in congenital afibrinogenemia. A comparison with ristocetin.
    Girolami A; Fabris F; Marco L; Peruffo R
    Acta Haematol; 1976; 56(3):151-9. PubMed ID: 826070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet adhesiveness and aggregation in congenital afibrinogenemia. An investigation of three patients with post-transfusion, cross-correction studies between two of them.
    Girolami A; De Marco L; Virgolini L; Peruffo R; Fabris F
    Blut; 1975 Feb; 30(2):87-100. PubMed ID: 1111662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between ristocetin-induced platelet aggregation and factor VIII (activity and antigen) in v. Willebrand's disease.
    Barbui T; Battista R; Dini E
    Blut; 1974 Oct; 29(4):260-4. PubMed ID: 4547631
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC; Deykin D
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The laboratory diagnosis of von Willebrand's disease (author's transl)].
    Niessner H
    Wien Klin Wochenschr; 1976 Apr; 88(7):221-31. PubMed ID: 1086551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Platelet function in congenital hemorrhagic diathesis (author's transl)].
    Izuchi Y; Deguchi K
    Rinsho Ketsueki; 1975 Apr; 16(4):415-22. PubMed ID: 1079885
    [No Abstract]   [Full Text] [Related]  

  • 10. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
    Barbui T; Dini E
    Acta Haematol; 1975; 53(1):44-8. PubMed ID: 807074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
    Olson JD; Brockway WJ; Fass DN; Magnuson MA; Bowie EJ
    Am J Clin Pathol; 1975 Feb; 63(2):210-8. PubMed ID: 1078748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand's disease type B: a newly defined bleeding diathesis.
    Firkin B; Firkin F; Stott L
    Aust N Z J Med; 1973 Jun; 3(3):225-9. PubMed ID: 4125893
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet aggregation and adhesiveness in classical factor X deficiency and in the abnormal factor X (factor X Friuli) coagulation disorder.
    Girolami A; Fabris F; Peruffo R; Coser P
    Acta Haematol; 1976; 56(5):307-13. PubMed ID: 826088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willebrand factor and ristocetin. I. Mechanism of rustocetin-induced platelet aggregation.
    Jenkins CS; Meyer D; Dreyfus MD; Larrieu MJ
    Br J Haematol; 1974 Dec; 28(4):561-78. PubMed ID: 4141901
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet responses to ristocetin in von Willebrand's disease.
    Sanderson JH; Burn AM; Cooke S
    Scand J Haematol; 1974; 12(4):249-55. PubMed ID: 4545782
    [No Abstract]   [Full Text] [Related]  

  • 16. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor.
    Bovill EG; Ershler WB; Golden EA; Tindle BH; Edson JR
    Am J Clin Pathol; 1986 Jan; 85(1):115-23. PubMed ID: 3079626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary giant platelet syndrome: a disorder of a new aspect of platelet function.
    Howard MA; Hutton RA; Hardisty RM
    Br Med J; 1973 Jun; 2(5866):586-8. PubMed ID: 4541347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aspirin on platelet aggregation and bleeding time in haemophilia and von Willebrand's disease.
    Praga C; Cortellaro M
    Acta Med Scand Suppl; 1971; 525():219-21. PubMed ID: 5317107
    [No Abstract]   [Full Text] [Related]  

  • 19. Assay of von Willebrand factor in von Willebrand's disease and hemophilia: use of a macroscopic platelet aggregation test.
    Brinkhous KM; Graham JE; Cooper HA; Allain JP; Wagner RH
    Thromb Res; 1975 Mar; 6(3):267-72. PubMed ID: 1078735
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.